FOXK1

Forkhead box protein K1 · P85037 · FOXK1 on Sugi Atlas →

0 patent compounds predicted against FOXK1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to FOXK1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt PHASE4COMPLETED
Compared the Efficacy and Safety of CDOP Combined With Chidamide and CDOP in de Novo Peripheral T Cell Lymphoma Patients PHASE3UNKNOWN
Effect of Silymarin in Metastatic Colorectal Cancer Patients PHASE3UNKNOWN
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
A Study of Bezafibrate in Mitochondrial Myopathy PHASE2COMPLETED
A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma PHASE2UNKNOWN
Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC) PHASE1COMPLETED
cePolyTregs in Islet Transplantation PHASE1WITHDRAWN
Influence of WNT4 VEZT FSHB and SIRT1 SNPs in Endometriosis: a Case Control Study of the Sardinian Population nanUNKNOWN
Psychiatric Phenotype Characterization of Individuals With FOXP1 Syndrome nanCOMPLETED
Expression of Longevity Genes in Response to Extended Fasting nanCOMPLETED
Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Can Dormant Perimenopausal Ovarian Follicles Become FSH Responsive? nanUNKNOWN
A Case Control Study of Resveratrol Effects in Coronary Artery Disease Patients With Metabolic Syndrome nanCOMPLETED
T Regulatory Cells in Hepatitis c Infected Patients nanCOMPLETED
Molecular Phenotype Changes and Personalized Treatment for CRPC nanUNKNOWN
Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics nanUNKNOWN
DCLK1 as a Marker/Indicator of Stem Cell Response in Barrett's Esophagus/Esophageal Adenocarcinoma nanCOMPLETED
Predictive Value of E-cadherin, β-catenin and SOX4 in Recurrence and/or Progression of Non-muscle Invasive Urinary Bladder Transitional Cell Carcinoma. A Retrospective Study nanCOMPLETED
Gene Expression Variation and Implant Wound Healing Among Smokers and Diabetics nanCOMPLETED
Metabolic Signalling in Muscle- and Adipose-tissue Following Insulin Withdrawal and Growth Hormone Injection. nanCOMPLETED
FOXP1 Syndrome: The Seaver Autism Center for Research and Treatment is Characterizing FOXP1-related Neurodevelopmental Disorders Using Genetic, Medical, and Neuropsychological Measures. nanRECRUITING
Dried Fruit and Postprandial Glycemia Trial nanUNKNOWN
Effects of Cardiac Rehabilitation on High Mobility Group Box-1 Levels After Acute Myocardial Infarction nanCOMPLETED
FoxO3a and PU.1 in Acute Lymphoblastic Leukemia nanUNKNOWN
Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients nanRECRUITING
T-regulatory Cells in Diabetic Type Two Nephropathy nanUNKNOWN
Investigation of Copy Number Variations and Genetic Variants in POI nanRECRUITING
Clinical Study of Desuzumab in the Treatment of Knee Osteoarthritis nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a FOXK1 binder may also engage these)

ProteinNameSimilarity
P42128 1.000 P42128 →
Q3UCQ1 0.998 Q3UCQ1 →
Q01167 0.997 Q01167 →
Q61060 0.996 Q61060 →
Q58NQ4 0.995 Q58NQ4 →
Q7ZX03 0.995 Q7ZX03 →
Q6F2E4 0.995 Q6F2E4 →
Q9H334 0.994 Q9H334 →
Q9PSY4 0.993 Q9PSY4 →
Q06453 0.993 Q06453 →
Q99958 0.993 Q99958 →
Q80TZ9 0.993 Q80TZ9 →
Q05B92 0.993 Q05B92 →
Q3Y598 0.993 Q3Y598 →
Q64732 0.992 Q64732 →
Q62901 0.992 Q62901 →
P06602 0.992 P06602 →
Q9VQ56 0.992 Q9VQ56 →
P79772 0.992 P79772 →
Q2EJA0 0.992 Q2EJA0 →
Q62431 0.992 Q62431 →
Q9HCS4 0.992 Q9HCS4 →
NR4A3 Nuclear receptor subfamily 4 group A member 3 0.992 landscape →
Q6NSM8 0.991 Q6NSM8 →
Q9Z1J1 0.991 Q9Z1J1 →
P23899 0.991 P23899 →
Q9JM73 0.991 Q9JM73 →
Q498D1 0.991 Q498D1 →
Q7TQ40 0.991 Q7TQ40 →
O93529 0.991 O93529 →